Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Biomarker Predicts Ability of Endurance Training to Improve Metabolic Health

By LabMedica International staff writers
Posted on 22 Jul 2019
Levels of the biomarker dimethylguanidino valeric acid in the blood are predicative of whether an individual can improve overall metabolic health through endurance training.

Considering the variable metabolic responses to exercise training, investigators at Beth Israel Deaconess Medical Center (Boston, MA, USA) examined the association between a novel circulating biomarker of hepatic fat, dimethylguanidino valeric acid (DMGV), and metabolic health traits before and after 20 weeks of endurance exercise training. More...
The choice of DMGV was based on previous findings, which showed that the molecule was a marker of liver fat and that circulating levels were linked to the development of type II diabetes up to 12 years prior to disease onset.

For the current study, the investigators determined blood levels of DMGV in nearly 440 otherwise healthy participants in the Health, Risk Factors, Exercise Training, and Genetics (HERITAGE) Family Study - a 20-week, single-arm endurance exercise clinical trial performed in multiple centers between 1993 and 1997 - before and after a chronic exercise training program. Metabolomic tests were performed using a liquid chromatography, tandem mass spectrometry method on plasma samples collected before and after exercise training in the HERITAGE study. Metabolomics and data analysis were performed from August 2017 to May 2018.

Results revealed that baseline levels of DMGV were positively associated with body fat percentage, abdominal visceral fat, very low-density lipoprotein cholesterol, and triglycerides, and inversely associated with insulin sensitivity, low-density lipoprotein cholesterol, high-density lipoprotein size, and high-density lipoprotein cholesterol. After adjusting for age, sex, and baseline traits, baseline DMGV levels were positively associated with changes in small high-density lipoprotein particles and inversely associated with changes in medium and total high-density lipoprotein particles and apolipoprotein A1, and insulin sensitivity after exercise training.

The results were interpreted to mean that DMGV was associated with adverse metabolic risk even in very young individuals free of overt disease. Regular exercise modulated circulating levels of DMGV, and these changes correlated with the changes in associated clinical traits after exercise training. Furthermore, higher baseline levels of DMGV were associated with reduced improvements in lipid traits and insulin sensitivity after exercise training.

"In our earlier work, what we found particularly compelling was the fact that patients who underwent weight loss surgery had decreases in DMGV,” said senior author Dr. Robert Gerszten, chief of cardiovascular medicine at Beth Israel Deaconess Medical Center. “In this new study, we were curious to see if exercise could also modulate levels of DMGV. Our findings indicate that DMGV levels may identify individuals who are less responsive to the metabolic health benefits of endurance exercise training and may require additional therapies beyond guideline-directed exercise to improve their metabolic health. These results highlight the potential application of metabolomics to inform targeted exercise therapy.”

The study was published in the June 5, 2019, online edition of the journal JAMA Cardiology.

Related Links:
Beth Israel Deaconess Medical Center


Gold Member
Veterinary Hematology Analyzer
Exigo H400
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Staining Management Software
DakoLink
New
Hand-Held Immunofluorescence Analyzer
WS-Si1500
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.